Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis

NCT07376512 is registered in ClinicalTrials.gov with Centre Georges Francois Leclerc as lead sponsor.

NCT NCT07376512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07376512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis
Lead sponsor
Centre Georges Francois Leclerc
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2026
Completion date
March 1, 2030
Enrollment
378 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin cancer), non-small cell lung cancer